DP VII Associates L.P., 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 35,253 shares at $14.00 ($67K) on 2013-07-01, disclosed to the SEC on 2013-07-02.
Open-market purchase of $67k ESPR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 30,462 | $0 | 0.0% |
| 2 | $14.00 | 4,791 | $67K | 100.0% |
| Total | $1.90 avg | 35,253 | $67K | 100% |
| Filing → |
| EVOK | SELL | 2016-04-21 | $4K | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |
| CADX | SELL | 2013-02-01 | $2K | — | Filing → |